Turning Point Brands, Inc. Q3 2026 Earnings Call Summary Moby Intelligence Mon, November 9, 2026 at 5:13 PM EST 2 min read NVDA -4.09% TPB -3.98% Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Modern Oral now accounts for 49% of total revenue, driven by triple-digit year-over-year growth in the FRE and ALP nicotine pouch brands.
Management is prioritizing chain account placements over independent retail to establish durable brand equity and capture the majority of category volume.
The company is leveraging cash flow from heritage businesses like Zig-Zag and Stoker's to fund the high-growth transition into the nicotine pouch market.
Operational focus has shifted toward building a robust sales force to ensure product availability and merchandising execution as the retail footprint scales.
Strategic marketing is becoming more selective, redirecting resources from early awareness programs toward high-return initiatives and retail activation.
The company expects to increase its chain store count by more than 70% during 2026, leveraging long-term retail partnerships.
Domestic manufacturing is projected to commence in 2027, which management identifies as a critical driver for long-term profitability and margin expansion.
A dual-track PMTA strategy is being employed to pursue U.S. manufacturing approval without disrupting the existing regulatory review timeline.
Full-year guidance assumes continued consumer adoption and a back-end loaded revenue cadence typical of the fourth quarter.
Management scaled back SG&A by almost $2 million sequentially by identifying and cutting marketing investments with inadequate returns.
The company expects to spend roughly $3.5 million in the fourth quarter specifically to support its PMTA regulatory submissions.
One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.
FRE is currently deploying into chain accounts won earlier in the year, while ALP is focused on independent retail and spring chain resets.
Management expects ALP to follow FRE's trajectory into national chains as negotiations for 2027 placements progress.
The company is using a secondary PMTA pathway to add the Louisville site as a primary manufacturing location.
This dual-track approach avoids the risk of the FDA requiring new tests for the original application if the manufacturing site were changed mid-review.
Management anticipates a 'culling of the herd' as the category matures, weeding out smaller competitors.
FRE and ALP are positioned to be among the few 'ubiquitously distributed' brands carried in most U.S. stores.
Higher SKU counts per store correlate with better velocity for both brands, leading to increased assortment in successful accounts.
Early data from ALP's independent retail rollout is meeting or exceeding management's internal expectations.
